<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effectiveness of preventive and therapeutic measures depends upon their adequacy in the individual diagnostic situation </plain></SENT>
<SENT sid="1" pm="."><plain>This is also true for <z:hpo ids='HP_0001297'>stroke</z:hpo> which is a superimposed concept for different mechanisms leading to <z:hpo ids='HP_0011009'>acute</z:hpo> localized <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>For the choice of treatment we have to consider in each case the actual clinical situation, i.e. the natural stage of disease, the localization of <z:e sem="disease" ids="C0262405" disease_type="Disease or Syndrome" abbrv="">cerebral dysfunction</z:e> and its etiology and pathogenesis </plain></SENT>
<SENT sid="3" pm="."><plain>Thus <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>), completed <z:hpo ids='HP_0001297'>stroke</z:hpo> with prolonged complete, partial or no recovery and progressive <z:hpo ids='HP_0001297'>stroke</z:hpo> (<z:hpo ids='HP_0001297'>stroke</z:hpo> in evolution) demand different treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Concerning pathogenesis it is important to differentiate between <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo>, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> due to extracranial <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> or occlusion, intracranial <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, predominantly hemodynamic pathogenesis and embolism of cardiac origin </plain></SENT>
<SENT sid="5" pm="."><plain>Prevention of <z:hpo ids='HP_0001297'>stroke</z:hpo> may be of general kind like treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo> or other risk factors for <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e>, and there are more specific measures like surgery of vascular obliteration and treatment with agents inhibiting platelet aggregation (Aspirin) or <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The indications for the various surgical and medical procedures are discussed </plain></SENT>
<SENT sid="7" pm="."><plain>Because of the risk of hemorrhagic complications the indication for <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> is limited considerably </plain></SENT>
<SENT sid="8" pm="."><plain>The treatment of completed <z:hpo ids='HP_0001297'>stroke</z:hpo> has to consider the normalization of basic functions (cardiocirculatory, respiration, water-electrolyte balance a.o.) </plain></SENT>
<SENT sid="9" pm="."><plain>Vasoactive and especially vasodilatatory drugs are not recommended in the <z:hpo ids='HP_0011009'>acute</z:hpo> stage of <z:hpo ids='HP_0001297'>stroke</z:hpo>, as their effectiveness is not secure and may even be disadvantageous </plain></SENT>
<SENT sid="10" pm="."><plain>Ischemic <z:hpo ids='HP_0002181'>brain edema</z:hpo> is treated with <z:chebi fb="1" ids="29864">mannitol</z:chebi> or sorbit and with <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> although its effectiveness has not yet been proven </plain></SENT>
<SENT sid="11" pm="."><plain>Low molecular <z:chebi fb="0" ids="52071">dextran</z:chebi> solution is supposed to improve microcirculation in the ischemic tissue by means of hemodilution i.e. improvement of rheological properties </plain></SENT>
</text></document>